Literature DB >> 20722025

Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities.

Rajeev Saggar1, Dinesh Khanna, Daniel E Furst, Shelley Shapiro, Paul Maranian, John A Belperio, Neeraj Chauhan, Philip Clements, Alan Gorn, S Sam Weigt, David Ross, Joseph P Lynch, Rajan Saggar.   

Abstract

OBJECTIVE: Exercise-induced pulmonary hypertension (PH) may represent an early but clinically relevant phase in the spectrum of pulmonary vascular disease. There are limited data on the prevalence of exercise-induced PH determined by right heart catheterization in scleroderma spectrum disorders. We undertook this study to describe the hemodynamic response to exercise in a homogeneous population of patients with scleroderma spectrum disorders at risk of developing pulmonary vascular disease.
METHODS: Patients with normal resting hemodynamics underwent supine lower extremity exercise testing. A classification and regression tree (CART) analysis was used to assess combinations of variables collected during resting right heart catheterization that best predicted abnormal exercise physiology, applicable to each individual subject.
RESULTS: Fifty-seven patients who had normal resting hemodynamics underwent subsequent exercise right heart catheterization. Four distinct hemodynamic groups were identified during exercise: a normal group, an exercise-induced pulmonary venous hypertension (ePVH) group, an exercise out of proportion PH (eoPH) group, and an exercise-induced PH (ePH) group. The eoPH and ePVH groups had higher pulmonary capillary wedge pressure (PCWP) than the ePH group (P < 0.05). The normal and ePH groups had exercise PCWP ≤18 mm Hg, which was lower than that in the ePVH and eoPH groups (P < 0.05). During submaximal exercise, the transpulmonary gradient and pulmonary vascular resistance (PVR) were elevated in the ePH and eoPH groups as compared with the normal and ePVH groups (P < 0.05). CART analysis suggested that resting mean pulmonary artery pressure (mPAP) ≥14 mm Hg and PVR ≥160 dynes/seconds/cm(-5) were associated with eoPH and ePH (positive predictive value 89% for mPAP 14-20 mm Hg and 100% for mPAP >20 mm Hg).
CONCLUSION: We characterized the exercise hemodynamic response in at-risk patients with scleroderma spectrum disorders who did not have resting PH. Four distinct hemodynamic groups were identified during exercise. These groups may have potentially different prognoses and treatment options.
Copyright © 2010 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2010        PMID: 20722025      PMCID: PMC7065301          DOI: 10.1002/art.27695

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  49 in total

1.  Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension.

Authors:  D A Raeside; A Smith; A Brown; K R Patel; R Madhok; J Cleland; A J Peacock
Journal:  Eur Respir J       Date:  2000-08       Impact factor: 16.671

2.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

3.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

Review 4.  Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.

Authors:  G Kovacs; A Berghold; S Scheidl; H Olschewski
Journal:  Eur Respir J       Date:  2009-03-26       Impact factor: 16.671

5.  Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis.

Authors:  Kunio Hamada; Sonoko Nagai; Shigeru Tanaka; Tomohiro Handa; Michio Shigematsu; Taishi Nagao; Michiaki Mishima; Masanori Kitaichi; Takateru Izumi
Journal:  Chest       Date:  2007-02-22       Impact factor: 9.410

6.  Pulmonary hypertension in systemic lupus.

Authors:  S R Johnson; D D Gladman; M B Urowitz; D Ibañez; J T Granton
Journal:  Lupus       Date:  2004       Impact factor: 2.911

7.  Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience.

Authors:  S Murali; R L Kormos; B F Uretsky; D Schechter; P S Reddy; B G Denys; J M Armitage; R L Hardesty; B P Griffith
Journal:  Am Heart J       Date:  1993-10       Impact factor: 4.749

8.  Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis.

Authors:  D Mukerjee; D St George; C Knight; J Davar; A U Wells; R M Du Bois; C M Black; J G Coghlan
Journal:  Rheumatology (Oxford)       Date:  2004-01-06       Impact factor: 7.580

9.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

10.  Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.

Authors:  Robin Condliffe; David G Kiely; Andrew J Peacock; Paul A Corris; J Simon R Gibbs; Florenc Vrapi; Clare Das; Charlie A Elliot; Martin Johnson; Julia DeSoyza; Chantal Torpy; Kim Goldsmith; Denise Hodgkins; Rodney J Hughes; Joanna Pepke-Zaba; J Gerry Coghlan
Journal:  Am J Respir Crit Care Med       Date:  2008-10-17       Impact factor: 21.405

View more
  26 in total

1.  Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.

Authors:  Sangmee Bae; Rajeev Saggar; Marcy B Bolster; Lorinda Chung; Mary Ellen Csuka; Chris Derk; Robyn Domsic; Aryeh Fischer; Tracy Frech; Avram Goldberg; Monique Hinchcliff; Vivien Hsu; Laura Hummers; Elena Schiopu; Maureen D Mayes; Vallerie McLaughlin; Jerry Molitor; Nausheen Naz; Daniel E Furst; Paul Maranian; Virginia Steen; Dinesh Khanna
Journal:  Ann Rheum Dis       Date:  2012-02-02       Impact factor: 19.103

2.  Rest and exercise echocardiography for early detection of pulmonary hypertension.

Authors:  Kenya Kusunose; Hirotsugu Yamada
Journal:  J Echocardiogr       Date:  2015-11-30

3.  Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.

Authors:  Dinesh Khanna; Heather Gladue; Richard Channick; Lorinda Chung; Oliver Distler; Daniel E Furst; Eric Hachulla; Marc Humbert; David Langleben; Stephen C Mathai; Rajeev Saggar; Scott Visovatti; Nezam Altorok; Whitney Townsend; John FitzGerald; Vallerie V McLaughlin
Journal:  Arthritis Rheum       Date:  2013-12

Review 4.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

Review 5.  Exercise-induced pulmonary hypertension: physiological basis and methodological concerns.

Authors:  Robert Naeije; Rebecca Vanderpool; Bishnu P Dhakal; Rajeev Saggar; Rajan Saggar; Jean-Luc Vachiery; Gregory D Lewis
Journal:  Am J Respir Crit Care Med       Date:  2013-01-24       Impact factor: 21.405

Review 6.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

7.  Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure.

Authors:  Gustavo A Heresi; Omar A Minai; Adriano R Tonelli; Jeffrey P Hammel; Samar Farha; Joseph G Parambil; Raed A Dweik
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 8.  Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Eric D Austin; Steven M Kawut; Mark T Gladwin; Steven H Abman
Journal:  Ann Am Thorac Soc       Date:  2014-04

9.  Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension.

Authors:  Jason L Sanders; Yuchi Han; Mariana F Urbina; David M Systrom; Aaron B Waxman
Journal:  Pulm Circ       Date:  2019-10-30       Impact factor: 3.017

10.  Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Authors:  Rudolf K F Oliveira; Aaron B Waxman; Paul J Hoover; Paul F Dellaripa; David M Systrom
Journal:  Chest       Date:  2020-03-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.